Gait analysis in Parkinson's disease and response to dopaminergic treatment;Análisis de la marcha en la enfermedad de Parkinson y su respuesta al tratamiento dopaminérgico

Medicina Clinica

Volumn 124, Issue 2, 2005, Pages 50-52

  Moreno Izco, Fermín ^a,c   Poza Aldea, Juan José ^b   Martí Massó, José Félix ^b   López De Munáin, Adolfo ^b  

^a Ilundain Fundazioa   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c HOSPITAL DE ZUMÁRRAGA   (Spain)

Author keywords

Gait; Levodopa; Parkinson disease

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAIT; GAIT DISORDER; HIP; HUMAN; KNEE; MALE; PARKINSON DISEASE; PHOTOGRAPHY; TREATMENT OUTCOME; VELOCITY;

EID: 13444278634     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13070451     Document Type: Article

References (10)

1. Blin O, Ferrández AM, Serratrice G. Quantitative analysis of gait in Parkinson patients: increased variability of stride length. J Neurol Sci. 1990; 98:91-7.
2. Bowes SG, Charlett A, Dobbs RJ, Lubet DD, Mehta R, O'Neill CJ, et al. Gait in relation to aging and idiopathic parkinsonism. Scand J Rehabil Med. 1992;24:181-6.
3. Zijlmans JC, Poels PJ, Duysens J, Van der Straaten J, Thien T, Van't Hof MA, et al. Quantitative gait analysis in patients with vascular parkinsonism. Mov Disord. 1996;11:501-8.
4. Ebersbach G, Sojer M, Valldeoriola F, Wissel J, Müller J, Tolosa E, et al. Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain. 1999;122:1349-55.
5. Stolze H, Kuhtz-Buschbeck JP, Drüke H, Johnk K, Illert M, Deuschl G. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psych. 2001;70:289-97.
6. Blin O, Ferrández AM, Pailhous J, Serratrice G. Dopa-sensitive and dopa-resistant gait parameters in Parkinsons disease. Neurol Sci. 1991;103:51-4.
7. O'Sullivan J, Said CM, Dillon LC, Hoffman M, Hughes AJ. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function. Mov Disord. 1998;13:900-6.
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55:181-4.
9. Morris ME, McGinley J, Huxham F, Collier J, Iansek R. Constraints on the kinetic, kinematic and spatiotemporal parameters of gait in Parkinson's disease. J Hum Movement Sci. 1999; 18:461-83.
10. Sonnet AM, Loria MH, Saint-Hilaire, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology. 1987;37:1539-42.